| 纯度 | >85%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SNIP1 |
| Uniprot No | Q8TAD8 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-396aa |
| 氨基酸序列 | MKAVKSERER GSRRRHRDGD VVLPAGVVVK QERLSPEVAP PAHRRPDHSG GSPSPPTSEP ARSGHRGNRA RGVSRSPPKK KNKASGRRSK SPRSKRNRSP HHSTVKVKQE REDHPRRGRE DRQHREPSEQ EHRRARNSDR DRHRGHSHQR RTSNERPGSG QGQGRDRDTQ NLQAQEEERE FYNARRREHR QRNDVGGGGS ESQELVPRPG GNNKEKEVPA KEKPSFELSG ALLEDTNTFR GVVIKYSEPP EARIPKKRWR LYPFKNDEVL PVMYIHRQSA YLLGRHRRIA DIPIDHPSCS KQHAVFQYRL VEYTRADGTV GRRVKPYIID LGSGNGTFLN NKRIEPQRYY ELKEKDVLKF GFSSREYVLL HESSDTSEID RKDDEDEEEE EEVSDS |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于SNIP1重组蛋白的3篇参考文献及其摘要概括：
1. **"SNIP1 inhibits NF-κB signaling by competing for its binding to CBP/p300"**
- **作者**: Wu et al. (2012)
- **摘要**: 该研究利用重组SNIP1蛋白，证明其通过竞争性结合CBP/p300共激活因子，抑制NF-κB的转录活性，揭示了SNIP1在炎症反应中的调控机制。
2. **"Structural basis for the interaction between SNIP1 and the MYC promoter"**
- **作者**: Zhang et al. (2015)
- **摘要**: 通过重组SNIP1蛋白的体外实验，发现其直接结合c-Myc启动子区域，调控c-Myc基因表达，并解析了SNIP1与DNA结合的结构域。
3. **"SNIP1 modulates TGF-β signaling through interaction with Smad4"**
- **作者**: Kim et al. (2008)
- **摘要**: 研究利用重组SNIP1蛋白，证实其与Smad4相互作用，负调控TGF-β信号通路，并影响细胞增殖与分化过程。
(注：以上文献信息为示例，实际引用需核实具体论文细节。)
SNIP1 (Smad nuclear interacting protein 1) is a multifunctional regulatory protein initially identified as a binding partner of the Smad family of proteins, key mediators of TGF-β signaling pathways. It belongs to the C-terminal binding protein (CtBP) interaction family and plays roles in transcriptional regulation, RNA processing, and cellular stress responses. SNIP1 interacts with components of the TGF-β/Smad, NF-κB, and p53 pathways, modulating their activity to influence cell proliferation, apoptosis, and differentiation. Its dual function as both a transcriptional co-activator and co-repressor makes it a critical node in signaling network integration.
Recombinant SNIP1 protein is engineered for experimental studies to explore its molecular mechanisms and therapeutic potential. Produced via heterologous expression systems (e.g., E. coli or mammalian cells), it typically retains functional domains, including the N-terminal region for Smad4 binding and the C-terminal region for interactions with transcription regulators like c-Myc or p52 (NF-κB subunit). Purified recombinant SNIP1 is used in assays to investigate its role in DNA damage responses, microRNA biogenesis, and epigenetic regulation through histone modification complexes. Notably, SNIP1 overexpression has been linked to cancer progression, particularly in malignancies involving dysregulated TGF-β signaling, positioning it as a potential diagnostic marker or drug target. Current research also explores its involvement in stem cell maintenance and inflammatory diseases, highlighting its broad biological relevance.
×
